DNLI
Price
$14.37
Change
-$0.06 (-0.42%)
Updated
May 9 closing price
Capitalization
2.09B
81 days until earnings call
TELO
Price
$2.49
Change
-$0.03 (-1.19%)
Updated
May 9 closing price
Capitalization
74.11M
17 days until earnings call
Ad is loading...

DNLI vs TELO

Header iconDNLI vs TELO Comparison
Open Charts DNLI vs TELOBanner chart's image
Denali Therapeutics
Price$14.37
Change-$0.06 (-0.42%)
Volume$1.37M
Capitalization2.09B
Telomir Pharmaceuticals
Price$2.49
Change-$0.03 (-1.19%)
Volume$105.44K
Capitalization74.11M
DNLI vs TELO Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. TELO commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and TELO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (DNLI: $14.37 vs. TELO: $2.49)
Brand notoriety: DNLI and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 94% vs. TELO: 61%
Market capitalization -- DNLI: $2.09B vs. TELO: $74.11M
DNLI [@Biotechnology] is valued at $2.09B. TELO’s [@Biotechnology] market capitalization is $74.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, DNLI is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while TELO’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • TELO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TELO is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -12.59% price change this week, while TELO (@Biotechnology) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

TELO is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.09B) has a higher market cap than TELO($74.1M). DNLI YTD gains are higher at: -29.490 vs. TELO (-39.563). TELO has higher annual earnings (EBITDA): -12.19M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. TELO (1.27M). DNLI (0) and TELO (0) have equivalent revenues.
DNLITELODNLI / TELO
Capitalization2.09B74.1M2,818%
EBITDA-505.16M-12.19M4,143%
Gain YTD-29.490-39.56375%
P/E RatioN/AN/A-
Revenue00-
Total Cash818M1.27M64,613%
Total Debt48.6MN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLITELO
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 20 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLPFX12.72N/A
N/A
Catalyst Nasdaq-100 Hedged Equity I
IYBIX23.41N/A
N/A
Macquarie Balanced Fund Class I
JEPSX13.83-0.01
-0.07%
JPMorgan Equity Premium Income R5
VFMFX40.16-0.04
-0.10%
Vanguard US Multifactor Admiral™
MMGEX8.43-0.01
-0.12%
MassMutual Small Cap Gr Eq A

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-0.42%
BEAM - DNLI
55%
Loosely correlated
+0.93%
ARWR - DNLI
55%
Loosely correlated
-1.66%
ACLX - DNLI
55%
Loosely correlated
+2.29%
RGNX - DNLI
54%
Loosely correlated
+5.17%
NRIX - DNLI
53%
Loosely correlated
-1.45%
More

TELO and

Correlation & Price change

A.I.dvisor tells us that TELO and ATXS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELO and ATXS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-1.19%
ATXS - TELO
31%
Poorly correlated
-3.86%
APGE - TELO
29%
Poorly correlated
-1.38%
ENGN - TELO
29%
Poorly correlated
-12.68%
ALZN - TELO
29%
Poorly correlated
+21.87%
DNLI - TELO
27%
Poorly correlated
-0.42%
More